Washington, July 24 (ANI): Study of a drug for people with type 2 diabetes conducted in 32 countries including India has confirmed that the oral DPP-4 inhibitor linagliptin is a safe and effective means of lowering glucose levels for up to 102 weeks, either on its own or in combination with other selected oral anti-diabetic medication.